Guideline Swine Flu

What is swine influenza?
Swine Influenza (swine flu) is a respiratory disease of pigs caused by type A influenza virus that regularly causes outbreaks of influenza in pigs. Swine flu viruses cause high levels of illness and low death rates in more

Contact Us

Head Office
54-55, Shree Siddhi Vinayak Industrial Area.
Udaipur Kanla, Tikawada (RAJASTHAN)


Corporate Overview

mediLexicon is a fully integrated healthcare company that delivers innovative biopharmaceutical solutions. From discovery to development and commercialization, we have the defining science, cost-effective drug development capabilities and significant manufacturing capacity to move ideas to market.

Leveraging India's globally competitive cost base and exceptional scientific people resource, we are advancing our in-house R&D programs, while also providing custom and clinical research services to international pharmaceutical and biotechnology majors through our subsidiary companies.

mediLexicon has rapidly developed a robust drug pipeline, led by monoclonal antibodies and several other molecules at exciting stages in the biopharmaceutical value chain. With the successful commercial launch of our first anti-cancer drug and several promising discovery partnerships in the clinic, we remain committed to scaling new heights in frontier science and achieving new milestones in affordable medicine.

Go to Top


mediLexicon's manufacturing facilities, spread across India, play a critical role in enabling the Company realize its global aspirations, benchmarked to International standards, these facilities are approved by international regulatory agencies.

Go to Top


The Company's intellectual pool of over 100 scientists is constantly engaged in path breaking research. Its focus on drug discovery and advanced drug delivery systems research has resulted in significant progress in its Drug Discovery & Development program and development of platform technologies that are being used to develop value-added generic pharmaceuticals. Company's strong focus on creating Intellectual Property (IP) assets has resulted in generating revenue streams through IP. The Company's overall research prowess enables it to master cutting edge science and technology.

Go to Top


An organization is as dynamic and effective as its people. At mediLexicon, the vast experience of our distinguished Board of Directors, the invaluable learning of the Scientific Advisory Board and the strategic focus of the Key Management Team steer us towards our goals. They are amply supported by a strong team of exemplary bioscientists, engineers and business managers who build our intellectual capital and drive our growth.

Go to Top


Our overall management and supervision is undertaken by the Board. Our day-to-day management is the responsibility of the Managing Director who is assisted by two Whole time Directors under the supervision, direction and control of the Board. A team of professionals forms the next level of management with responsibility for the divisions or functional areas that they lead.

Go to Top


mediLexicon follows good manufacturing, laboratory and documentation practices that ensure consistent high quality results. Our state-of-the-art analytical facilities monitor and maintain strict quality of our products, processes and services, consistently meeting EDQM, USP and other national and international quality standards.

mediLexicon's quality chain covers three key functional areas:

  • - Quality Control
  • - Quality Assurance
  • - Regulatory Affairs

Quality Control (QC) is responsible for all analyses undertaken at mediLexicon. From analytical support during product development and validations to training mediLexicon customers, QC is supported by a highly qualified team of professionals.

Quality Assurance (QA) comprises of Corporate QA and Site QA.

  • - Site QA is responsible for implementation of quality systems and release of all manufactured products.
  • - Corporate QA develops and ensures harmonization of all systems throughout the organization. It is also responsible for all audits including regulatory (national and international), customer, GMP, GLP and GCP.

Go to Top


To be an integrated biotechnology enterprise of global distinction.

Essential to this mission is excellence in:

  • - Intellectual asset creation through discovery, research and development
  • - State-of-the-art manufacturing capabilities
  • - Internationally benchmarked quality and regulatory systems
  • - New medical insight through disease specific clinical research
  • - Customer relationship through outstanding products and services
  • - Human resource development through training, mentoring and empowering
  • - Management of research and business partnerships

Go to Top

Objects of the Company

Our main objects as contained in our Memorandum of Association are:
To carry on the business of manufacturing, processing, distilling, compounding, formulating, acquiring, buying, selling, importing, exporting and dealing in all enzyme products from animal, microbial, plant sources, products from fish sources, vegetable and herb extracts, agricultural products including cattle feed, and all chemicals heavy or fine, organic, inorganic, biological or any other formulations, derivatives and compounds thereof from mineral origin or from other chemicals or from by-products or waste products of other trades and industries and other branded preparations and compounds, derivatives and formulations thereof and consumers products based thereon, pharmaceutical specialties, surgical specialties, cosmetics, germicides, detergents and acids

To establish and run an extraction plant for the extraction of oils, coloring matters, crude drugs and other extracts from seeds, barks, cakes, flowers, plants in all forms for the production of natural colorants, alkaloids, steroids, other drugs and medicines and other products.

To cultivate, crush, utilize, buy sell and deal in seeds, substances, and plants of every description. The main objects clause and the objects incidental or ancillary to the main objects of the Memorandum of Association of mediLexicon enable us to undertake our existing activities and the activities for which the funds are being raised through this Issue.

Go to Top